{
    "success": true,
    "data": {
        "leverage": true,
        "derivatives": true,
        "swaps": false,
        "inverse": true,
        "replication_method": "synthetic",
        "ucits": false,
        "type": "ETP",
        "complex_factors": [
            "Leverage",
            "Inverse Strategy",
            "Compounding Risk",
            "Daily Rebalancing",
            "Synthetic Replication"
        ],
        "classification": "complex",
        "supporting_data": "The product is classified as complex based on several unambiguous features. Firstly, it is a Leveraged and Inverse ETP offering '-3x' the daily performance of the underlying index, a structure that is inherently complex and not suitable for investors without advanced knowledge. The use of leverage is integral to the product's investment objective, not for efficient portfolio management. The KID explicitly warns about the 'Compounding Effect' due to daily rebalancing, which can cause returns to deviate significantly from the target over periods longer than one dayu2014a concept difficult for the average retail investor to understand. The product is not a UCITS and therefore does not benefit from the presumption of non-complexity; in fact, its features are incompatible with UCITS diversification and leverage rules. The replication method is synthetic, as it does not hold the underlying assets but uses collateral assets in a margin account and engages in securities lending to achieve its objective, introducing counterparty and collateral risks. Finally, the KID itself contains a comprehension alert: 'You are about to purchase a product that is not simple and may be difficult to understand' and states it is intended for 'sophisticated investors', confirming its complex nature under MiFID II. The product falls under the category of instruments that are always complex as per ESMA guidelines (e.g., Q&A on Appropriateness), due to its structure making it difficult for a client to understand the risks involved."
    }
}